Cardian

About:

Cardian has been formed to commercialise a novel implantable device

Top Investors: Touchstone Innovations

Description:

Cardian has been formed to commercialise a novel implantable device that improves the monitoring and treatment of cardiac failure patients, by providing completely automated, continuous wireless monitoring of blood pressure in the pulmonary artery. Following this investment, Innovations will hold a 53.7% interest in the Company, comprising a combination of founders equity and 27.3% derived from investment.